Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers

被引:53
|
作者
Singh, Krishna [1 ]
Lester, Jenny [2 ]
Karlan, Beth [2 ]
Bresee, Catherine [2 ]
Geva, Tali [1 ]
Gordon, Ora [1 ]
机构
[1] Cedars Sinai Med Ctr, Cedars Sinai Med Genet Inst, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA
关键词
BRCA mutations; family history; prophylactic mastectomy; prophylactic salpingo-oophorectomy; SALPINGO-OOPHORECTOMY; OVARIAN-CANCER; BREAST; WOMEN; TIME;
D O I
10.1016/j.ajog.2013.01.026
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Despite substantial survival benefits of risk-reducing mastectomy (RRM) and risk-reducing bilateral salpingo-oophorectomy (RRBSO) among BRCA mutation carriers, only a minority elect to undergo these procedures. This study investigates factors that might influence decision making regarding prophylactic surgeries among women with BRCA mutations. STUDY DESIGN: Unaffected BRCA mutation carriers who were counseled at our center and either underwent prophylactic surgery or participated in a high-risk surveillance program at our institution from 1998 through 2010 were included in the study. Medical records were reviewed and data collected included age, family history, parity, mutation type, history of breast biopsy or cosmetic surgery, and uptake of prophylactic surgeries. RESULTS: Among 136 unaffected women with BRCA mutations, uptake of RRM was 42% and uptake of RRBSO was 52%. Family history of first- and second-degree relatives being deceased from breast cancer was predictive of uptake of RRM and of RRBSO (odds ratio [OR], 11.0; P = .005; and OR, 15.8; P = .023, respectively), and history of a mother lost to pelvic cancer was predictive of uptake of RRBSO (OR, 7.9; P = .001). Parity also predicted both RRM and RRBSO uptake (OR, 4.2; P = .001; and OR, 5.4; P = .003, respectively). Age at the time of genetic testing and history of breast biopsy or cosmetic surgery were not predictive of RRM uptake. CONCLUSION: Perceptions of cancer risk are heavily influenced by particular features of an individual's family history and may be motivators in preventive surgery more than actual cancer risk estimations themselves. Awareness of subtle factors beyond the statistical risk for cancers is relevant when counseling at-risk women.
引用
收藏
页码:329.e1 / 329.e6
页数:6
相关论文
共 50 条
  • [21] Effect of risk-reducing salpingo-oophorectomy on the quality of life in Korean BRCA mutation carriers
    Chae, Sumin
    Kim, Eun-Kyu
    Jang, Ye Rang
    Lee, Angela Soeun
    Kim, Seul Ki
    Suh, Dong Hoon
    Kim, Kidong
    No, Jae Hong
    Kim, Yong-Beom
    Kim, Sung-Won
    Kang, Eunyoung
    ASIAN JOURNAL OF SURGERY, 2021, 44 (08) : 1056 - 1062
  • [22] Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing*
    Skytte, A-B
    Gerdes, A-M
    Andersen, M. K.
    Sunde, L.
    Brondum-Nielsen, K.
    Waldstrom, M.
    Kolvraa, S.
    Crueger, D.
    CLINICAL GENETICS, 2010, 77 (04) : 342 - 349
  • [23] Effects of False-Positive Cancer Screenings and Cancer Worry on Risk-Reducing Surgery Among BRCA1/2 Carriers
    Portnoy, David B.
    Loud, Jennifer T.
    Han, Paul K. J.
    Mai, Phuong L.
    Greene, Mark H.
    HEALTH PSYCHOLOGY, 2015, 34 (07) : 709 - 717
  • [24] THE FREQUENCY AND OUTCOME OF BREAST CANCER RISK-REDUCING SURGERY IN FINNISH BRCA1 AND BRCA2 MUTATION CARRIERS
    Koskenvuo, L.
    Svarvar, C.
    Suominen, S.
    Aittomaki, K.
    Jahkola, T.
    SCANDINAVIAN JOURNAL OF SURGERY, 2014, 103 (01) : 34 - 40
  • [25] Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia
    Lozar, Taja
    Zgajnar, Janez
    Perhavec, Andraz
    Blatnik, Ana
    Novakovic, Srdjan
    Krajc, Mateja
    EJSO, 2021, 47 (08): : 1900 - 1906
  • [26] Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers
    Nagura, Naomi
    Hayashi, Naoki
    Takei, Junko
    Yoshida, Atsushi
    Ochi, Tomohiro
    Iwahira, Yoshiko
    Yamauchi, Hideko
    BREAST CANCER, 2020, 27 (01) : 70 - 76
  • [27] Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers
    Rhiem, Kerstin
    Foth, Dolores
    Wappenschmidt, Barbara
    Gevensleben, Heidrun
    Buettner, Reinhard
    Ulrich, Uwe
    Schmutzler, Rita K.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (03) : 623 - 627
  • [28] Risk-reducing mastectomy in BRCA1/2 mutation carriers: Factors influencing uptake and timing
    van Driel, Catheleine M.
    Eltahir, Yassir
    de Vries, Jakob
    Jaspers, Jan P.
    Oosterwijk, Jan C.
    Mourits, Marian J.
    de Bock, Geertruida H.
    MATURITAS, 2014, 77 (02) : 180 - 184
  • [29] Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
    Marchetti, Claudia
    De Felice, Francesca
    Palaia, Innocenza
    Perniola, Giorgia
    Musella, Angela
    Musio, Daniela
    Muzii, Ludovico
    Tombolini, Vincenzo
    Panici, Pierluigi Benedetti
    BMC WOMENS HEALTH, 2014, 14
  • [30] A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing
    Harmsen, Marline G.
    Steenbeek, Miranda P.
    Hoogerbrugge, Nicoline
    van Doorn, Helena C.
    Gaarenstroom, Katja N.
    Vos, M. Caroline
    Massuger, Leon F. A. G.
    de Hullu, Joanne A.
    Hermens, Rosella P. . M. G.
    HEALTH EXPECTATIONS, 2018, 21 (03) : 659 - 667